EU Medicines Agency Recommends Boost in Manufacturing Capacity for Covid Vaccines
By Cecilia Butini
The European Medicines Agency said Friday that its human
medicines committee has adopted recommendations to increase
manufacturing capacity and supply of Covid-19 vaccines in the
The agency said it has approved an increase in batch size and
process scale-up at Pfizer Inc.'s manufacturing site in Puurs,
Belgium, a move which is expected to have a "significant" impact on
the supply of the vaccine it developed with BioNTech SE.
The agency's committee for medicinal products for human use also
recommended the approval of a new filling line at Moderna Inc.'s
manufacturing site in Rovi, Spain, the EMA said.
Write to Cecilia Butini at firstname.lastname@example.org
(END) Dow Jones Newswires
April 23, 2021 09:31 ET (13:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.